Jeff Sessions’ Latest Moves Should be a Wake-Up Call for the Cannabis Industry

The legal cannabis industry was recently rocked to its core by the announcement that Attorney General Jeff Sessions would be rescinding the so-called “Cole memo” and several other Obama-era legal directives suggesting the federal government would leave state-by-state cannabis reforms more or less alone. Suddenly, it seemed the entire cannabis […]

What’s Happening on Capitol Hill? Part 3: The Medical Bills

This article continues the bill-by-bill review begun in the August 1st article of cannabis reform legislation proposed in the 115th Congress. In the next article and final piece in this series, we will examine the banking and tax reform bills related to cannabis. Medical Cannabis Reform Bills  1008 – Therapeutic […]

Senate Committee Votes to Keep Medical Cannabis Protections

The Senate Appropriations Committee approved the amendment to continue protecting state-legal medical cannabis markets from the Department of Justice. The amendment, previously known as the Rohrabacher-Farr Amendment, prevents the DOJ from using funds to target medical cannabis operations, patients and businesses in states where it is legal. Every time Congress reviews […]

Hudak: “That legislation is dead. Period” – Cannabis Business Executive

By David Hodes Are we getting there? Let’s review: The National Organization for the Reform of Marijuana Laws (NORML) reports that twenty-nine states and the District of Columbia have legalized marijuana for qualified patients, while eight states now regulate the production and sale of marijuana to all adults. An estimated […]

Bipartisan Cannabis Reform Effort Unveiled in Congress

According to National Cannabis Industry Association (NCIA) executive director Aaron Smith, seven measures were introduced today at the Capitol, covering a variety of issues that, if signed into law, would ease many of the legal implications on the federal level affecting cannabis businesses in legal states currently. In a very […]